Chase AIPricingFAQs
Display currency
Loading news…

Centocor Ortho Biotech

Bridgewater, New Jersey, United States

Centocor develops monoclonal antibody-based products for cardiovascular and autoimmune diseases, cancer and inflammation.

Centocor Ortho Biotech was acquired by Janssen Biotech in 2008.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
1
Monthly Visits
Available in Pro
Contacts
0

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Company Info

Org types
company
HQ
Bridgewater, New Jersey, United States
Region
East Coast, Northeastern US

Acquisitions by Centocor Ortho Biotech

Loading columns…
0 of 0Show
Page 1 / 1

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Centocor Ortho Biotech

Loading news…

FAQs about Centocor Ortho Biotech

People who checked this page also checked these

Sectors Centocor Ortho Biotech invests & acquires in

M&A by year

Browse the full Acquirezy directory.
Centocor Ortho Biotech - Company Profile, Full Acquisitions List, Funding and Investments